» Articles » PMID: 7074800

Expansion of Acute Myocardial Infarction: an Experimental Study

Overview
Journal Circulation
Date 1982 Jun 1
PMID 7074800
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Expansion (regional dilatation and thinning) of acutely infarcted myocardium in man has been shown to correlate with overall cardiac dilatation and rupture. We studied gross and histopathologic features and the time course of expansion in rats. Infarcts were produced in 84 rats by ligation of the left coronary artery and studied at 1, 2, 3, 4, 5 and 7 days. All hearts were prepared by potassium diastolic arrest, gel distention and fixation. Expansion was graded 0 to 4+ : 1+, mild thinning of infarcted wall; 2+, mild thinning and dilatation; 3+, moderate thinning and dilatation; and 4+, marked thinning and dilatation. There were 80 transmural infarcts, and 66% showed expansion; 36 of 80 (45%) were graded 1-2+ and 17 of 80 (21%) 3-4+. None of the four exclusively nontransmural infarcts showed expansion. Expansion was present in 61% of transmural infarcts at 1-2 days, in 65% at 3-4 days and in 80% at 5-7 days. The percentage of rats with severe (3-4+) expansion increased markedly over this period, from 0% at 1-2 days to 23% at 3-4 days to 65% at 5-7 days. Histopathologic infarct evolution was roughly twice as rapid as that of humans; 5-7 day-old infarcts showed well-developed granulation tissue. Thus, expansion can be produced in an animal model. A critical infarct size of 17% appeared necessary for significant (greater than 1+) expansion, and the degree of expansion correlated with infarct size. Although this phenomenon begins early after infarction, its extent progresses over days, making interventions to interrupt its development feasible.

Citing Articles

Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids.

Song M, Choi D, Im J, Song Y, Kim J, Lee H Cell Death Dis. 2024; 15(5):308.

PMID: 38693114 PMC: 11063052. DOI: 10.1038/s41419-024-06703-9.


An inflammation resolution-promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction.

Hiram R, Xiong F, Naud P, Xiao J, Sosnowski D, Le Quilliec E Cardiovasc Res. 2023; 120(4):345-359.

PMID: 38091977 PMC: 10981525. DOI: 10.1093/cvr/cvad175.


Early reverse remodeling of left heart morphology and function evaluated by cardiac magnetic resonance in hypertrophic obstructive cardiomyopathy after transapical beating-heart septal myectomy.

Zhao Y, Li C, Tang D, Luo Y, Xiang C, Huang L J Cardiovasc Magn Reson. 2023; 25(1):70.

PMID: 38008762 PMC: 10680272. DOI: 10.1186/s12968-023-00987-0.


Protective Roles and Therapeutic Effects of Gallic Acid in the Treatment of Cardiovascular Diseases: Current Trends and Future Directions.

Momeni Z, Danesh S, Ahmadpour M, Eshraghi R, Farkhondeh T, Pourhanifeh M Curr Med Chem. 2023; 31(24):3733-3751.

PMID: 37815180 DOI: 10.2174/0109298673259299230921150030.


Cardiac rupture in acute myocardial infarction: a cardiac magnetic resonance study.

De Lazzari M, Cipriani A, Cecere A, Niero A, De Gaspari M, Giorgi B Eur Heart J Cardiovasc Imaging. 2023; 24(11):1491-1500.

PMID: 37200615 PMC: 10610764. DOI: 10.1093/ehjci/jead088.